2022 药房袖珍指南:过敏性鼻炎症状的管理

2022-10-05 欧洲过敏学和临床免疫学学会 Clin Transl Allergy 发表于上海

过敏性鼻炎 (AR) 管理需要医疗保健提供者和患者的协调努力。药剂师是这些综合护理途径的关键成员,他们解决与药物相关的问题、优化治疗方案、提高依从性和推荐疗法,同时在患者和医生之间建立联系。

中文标题:

2022 药房袖珍指南:过敏性鼻炎症状的管理

英文标题:

Management of allergic rhinitis symptoms in the pharmacy Pocket guide 2022

发布日期:

2022-10-05

简要介绍:

过敏性鼻炎 (AR) 管理需要医疗保健提供者和患者的协调努力。药剂师是这些综合护理途径的关键成员,他们解决与药物相关的问题、优化治疗方案、提高依从性和推荐疗法,同时在患者和医生之间建立联系。本文件无意成为强制性的护理标准,而是作为药师及其员工在当地执业环境下为患者制定相关的本地护理标准的基础。不同国家的药学护理也不尽相同,本指南应根据当地情况进行调整。

相关资料下载:
[AttachmentFileName(sort=1, fileName=Clinical Translational All - 2022 - Louren o - Management of allergic rhinitis symptoms in the pharmacy Pocket guide 2022.pdf)] GetToolGuiderByIdResponse(projectId=1, id=94f801c00283012e, title=2022 药房袖珍指南:过敏性鼻炎症状的管理, enTitle=Management of allergic rhinitis symptoms in the pharmacy Pocket guide 2022, guiderFrom=Clin Transl Allergy, authorId=0, author=, summary=过敏性鼻炎 (AR) 管理需要医疗保健提供者和患者的协调努力。药剂师是这些综合护理途径的关键成员,他们解决与药物相关的问题、优化治疗方案、提高依从性和推荐疗法,同时在患者和医生之间建立联系。, cover=https://img.medsci.cn/20221125/1669383391638_1608702.jpg, journalId=0, articlesId=null, associationId=2155, associationName=欧洲过敏学和临床免疫学学会 , associationIntro=欧洲过敏学和临床免疫学学会 (EAACI) , copyright=0, guiderPublishedTime=Wed Oct 05 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #1c1d1e;">过敏性鼻炎 (AR) 管理需要医疗保健提供者和患者的协调努力。</span><span style="color: #1c1d1e;">药剂师是这些综合护理途径的关键成员,他们解决与药物相关的问题、优化治疗方案、提高依从性和推荐疗法,同时在患者和医生之间建立联系。本文件无意成为强制性的护理标准,而是作为药师及其员工在当地执业环境下为患者制定相关的本地护理标准的基础。不同国家的药学护理也不尽相同,本指南应根据当地情况进行调整。</span></p>, tagList=[TagDto(tagId=9982, tagName=过敏性鼻炎)], categoryList=[CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=15, categoryName=风湿免疫, tenant=100), CategoryDto(categoryId=30, categoryName=耳鼻咽喉, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3494, appHits=88, showAppHits=0, pcHits=292, showPcHits=3405, likes=0, shares=11, comments=3, approvalStatus=1, publishedTime=Fri Dec 02 21:32:00 CST 2022, publishedTimeString=2022-10-05, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=8, createdBy=null, createdName=dajiong, createdTime=Fri Nov 25 21:36:27 CST 2022, updatedBy=6459136, updatedName=玉在山, updatedTime=Fri Jan 05 01:47:47 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=上海, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=Clinical Translational All - 2022 - Louren o - Management of allergic rhinitis symptoms in the pharmacy Pocket guide 2022.pdf)])
Clinical Translational All - 2022 - Louren o - Management of allergic rhinitis symptoms in the pharmacy Pocket guide 2022.pdf
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2104186, encodeId=b07821041868f, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Sun Dec 04 00:03:52 CST 2022, time=2022-12-04, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2104185, encodeId=72652104185b3, content=转发学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Sun Dec 04 00:03:47 CST 2022, time=2022-12-04, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2104184, encodeId=ca42210418480, content=谢谢受益, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Sun Dec 04 00:03:35 CST 2022, time=2022-12-04, status=1, ipAttribution=新疆)]
    2022-12-04 delianjihui 来自新疆

    感谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2104186, encodeId=b07821041868f, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Sun Dec 04 00:03:52 CST 2022, time=2022-12-04, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2104185, encodeId=72652104185b3, content=转发学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Sun Dec 04 00:03:47 CST 2022, time=2022-12-04, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2104184, encodeId=ca42210418480, content=谢谢受益, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Sun Dec 04 00:03:35 CST 2022, time=2022-12-04, status=1, ipAttribution=新疆)]
    2022-12-04 delianjihui 来自新疆

    转发学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2104186, encodeId=b07821041868f, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Sun Dec 04 00:03:52 CST 2022, time=2022-12-04, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2104185, encodeId=72652104185b3, content=转发学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Sun Dec 04 00:03:47 CST 2022, time=2022-12-04, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2104184, encodeId=ca42210418480, content=谢谢受益, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Sun Dec 04 00:03:35 CST 2022, time=2022-12-04, status=1, ipAttribution=新疆)]
    2022-12-04 delianjihui 来自新疆

    谢谢受益

    0